Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute Methiopropamine Intoxication After "Synthacaine" Consumption.

A Daveluy1, N Castaing2, H Cherifi3

  • 1Service de pharmacologie médicale, centre d'addictovigilance, CHU Bordeaux.

Journal of Analytical Toxicology
|July 31, 2016
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown.

Public health·2023
Same author

General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns.

The International journal on drug policy·2023
Same author

Methoxpropamine (MXPr) in powder, urine and hair samples: Analytical characterization and metabolite identification of a new threat.

Forensic science international·2022
Same author

Acute cardiovascular disorders related to aphrodisiac honey ("Jaguar power") consumption: Warning of unintentional exposure to sildenafil.

La Revue de medecine interne·2021
Same author

[Introduction of an anticholinesterase drug in the context of myasthenia, in a severe asthmatic patient].

Revue des maladies respiratoires·2021
Same author

Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same journal

Theory put into practice: probabilistic approach to propranolol as the cause of death.

Journal of analytical toxicology·2026
Same journal

Is drug facilitated sexual assault changing? About a case involving 4-bromomethcathinone.

Journal of analytical toxicology·2026
Same journal

Differentiation of 2-, 3-, and 4-Fluorofuranylfentanyl Using HPLC-MS and Human Liver Microsomes.

Journal of analytical toxicology·2026
Same journal

Trends and Circumstances of Pediatric Fentanyl Deaths in North Carolina: A 10-year Retrospective Study.

Journal of analytical toxicology·2026
Same journal

Drug Detection in Traffic-Related Fatalities in Connecticut (2020-2024).

Journal of analytical toxicology·2026
Same journal

Characterization of postmortem γ-hydroxybutyric acid (GHB) and a novel model to discern exogenous use.

Journal of analytical toxicology·2026
See all related articles
This summary is machine-generated.

Methiopropamine (MPA), a synthetic stimulant, caused acute toxicity in a patient using "synthacaine." This case highlights the need for advanced toxicological analysis to identify new psychoactive substances.

Area of Science:

  • Clinical Toxicology
  • Pharmacology
  • Forensic Science

Background:

  • Methiopropamine (MPA), a synthetic amphetamine analog, has been increasingly detected in Europe since 2011.
  • Limited data exists regarding the acute toxicity profile of MPA.

Observation:

  • A 30-year-old male presented with acute confusion, paranoia, and hallucinations after consuming "synthacaine."
  • Clinical examination revealed altered mental status and incoherent speech.

Findings:

  • Toxicological analysis using LC-MS-MS confirmed the presence of MPA in the patient's plasma.
  • MPA concentration was measured at 14 ng/mL, 13 hours post-admission.

Implications:

  • This case confirms the acute toxicity of methiopropamine.

Related Experiment Videos

  • Highlights the critical role of sophisticated toxicological screening in identifying novel psychoactive substances.
  • Underscores the potential dangers associated with designer drugs like synthacaine.